Investing
38 Articles
ThinkstockThursday may have been a mixed day in the markets with a gain in the S&P 500 and a drop…
We are seeing many key movers in the BioHealth space today. Biotech stocks and drug stocks are often more volatile…
If you think you are alone in noticing that the markets have held up extremely well, you better take a…
Biophama companies are horrible investments at least 90% of the time because they are gambles on the IQs of small groups of…
These are this morning’s top pre-market day trader alert stocks. We have more color and more detail on price and…
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has announced that dosing has commenced in its Phase IIa clinical trial with LX6171. This…
(AA) An ALCOA bid from BHP may be kindled according to numerous M&A reports.(ADVNA) Advanta trades ex-split to reflect a…
Lexicon Pharmaceuticals, Inc. (LXRX-NASDAQ) is a biotech company that many have not heard of, and those who do know it…
Our top personal finance-related articles today. Your wallet will thank you later.